Soluble tumor necrosis factor α receptor type 1 in psoriasis patients treated with narrowband ultraviolet B

Photodermatology Photoimmunology and Photomedicine

Volumn 21, Issue 4, 2005, Pages 210-211

  Serwin, Agnieszka Beata ^a   Sokolowska, Marianna ^b   Chodynicka, Bozena ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Diagnostic and Research Centre for Sexually Transmitted Diseases   (Poland)

Author keywords

Narrowband ultraviolet radiation; Psoriasis; Soluble TNF receptor type 1

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSORIASIS; SKIN DEFECT; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION;

ADOLESCENT; ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 22244472000     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2005.00164.x     Document Type: Article

References (5)

1. Brockhaus M, Schoenfeld H-J, Schlaeger E-J, Hunziker W, Lessauer W, Loetscher H. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 1990; 87: 3127-3131.
2. Griffiths CEM, Boffa MJ, Gallatin WM, Martin S. Elevated levels of circulating intercellular adhesion molecule-3 (cICAM-3) in psoriasis. Acta Derm Venereol (Stockholm) 1996; 76: 2-5.
3. Kirby B, Boffa MJ, Nayak N, Gallatin WM, Martin S, Griffiths CEM. The effect of treatment on serum levels of soluble intercellular adhesion molecules and tumor necrosis factor-receptor 1 in psoriasis. Br J Dermatol 2001; 145: 1027-1028.
4. Trefzer U, Brockhaus M, Loetscher H, et al. The 55-kD tumor necrosis factor receptor on human keratinocytes is regulated by tumor necrosis factor-alpha and by ultraviolet B radiation. J Clin Invest 1993; 92: 462-470.
5. Barr RM, Walker SL, Tsang W, et al. Suppressed alloantigen presentation, increased TNF-α, IL-1, IL-1Ra, IL-10, and modulation of TNF-R1 in UV-irradiated human skin. J Invest Dermatol 1999; 112: 692-698.